Stocks
G1 Therapeutics (GTHX) EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -95.5 | -142.5 | -134.9 | -134.9 | -39.0 | -35.4 | ||
| Changes by years, y/y, % | +49% | -5% | 0% | -71% | -15.3% | ||||
G1 Therapeutics. EBITDA US GAAP, bln rub
G1 Therapeutics. EBITDA US GAAP, changes, %
G1 Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
G1 Therapeutics (GTHX) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EBITDA, bln rub | ? | 12.9 | -15.1 | -8.81 | -8.93 | -2.62 | -35.4 | |
| Changes by years, y/y, % | -135% | -29% | -71% | -64% | -120% | |||
| Changes by quarters, q/q, % | -152% | -217% | -42% | +1% | -71% | |||
